Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
The current Regeneron(REGN) stock price is $623.54, with a market capitalization of 65.39B. The stock trades at a price-to-earnings (P/E) ratio of 15.39 and offers a dividend yield of 0.58%.
On 2026-06-30, Regeneron(REGN) stock moved within a range of $622.29 to $634.06. With shares now at $623.54, the stock is trading +0.2% above its intraday low and -1.7% below the session's peak.
Trading activity shows a volume of 818.09K, compared to an average daily volume of 1.21M.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $518.90.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $518.90.
REGN News
Eli Lilly (LLY), Regeneron (REGN), Amneal (AMRX), Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will parti...
Key Points Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in...
...
Analyst ratings
74%
of 31 ratingsMore REGN News
Earlier this week, Regeneron Pharmaceuticals reported that both the FDA and EMA accepted regulatory applications for cemdisiran to treat anti‑AChR antibody‑posi...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Pr...
Kiniksa Pharmaceuticals International KNSA is making steady progress, with strong commercial performance of Arcalyst, the first FDA-approved therapy for patient...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Pr...
With the Federal Reserve talking tougher on inflation and signaling a possible rate hike within months, investors are rethinking how comfortable they feel with...
Regeneron Pharmaceuticals (REGN) has drawn investor attention after recent trading that leaves the stock down about 3% over the past month and roughly 18% over...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.